24 results
8-K
EX-4.1
BCLI
Brainstorm Cell Therapeutics, Inc.
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm
8-K
EX-4.1
BCLI
Brainstorm Cell Therapeutics, Inc.
6 Mar 20
Entry into a Material Definitive Agreement
2:35pm
8-K
EX-4.1
37fi8vcn3sbtptqew
2 Aug 19
Entry into a Material Definitive Agreement
9:30am
8-K
EX-4.1
96g rgu5ced7vg
7 Jun 18
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
fcvdq 96sp3ve
8 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
e6sp7uz8hrowr 5eu7
16 Sep 14
BrainStorm Announces Completion of Reverse Split of Common Stock, a Key Step for Uplisting on the NASDAQ
12:00am
8-K
EX-4.1
ahpvd05pg fx3
13 Aug 13
BrainStorm Cell Therapeutics Announces Pricing of Underwritten Public Offering
12:00am
S-8
EX-4.3
gt5 sinicperyjyk
15 Feb 06
Registration of securities for employees
12:00am
S-8
EX-4.2
o5m 2mboyyw
15 Feb 06
Registration of securities for employees
12:00am
8-K
EX-4.10
ujyt05d 88qbr3mv1
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.09
dyafwto llk
3 Oct 05
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-4.08
6dm8dj
14 Feb 05
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-4.07
saitibgp
14 Feb 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.5
lq4ty3
28 Dec 04
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.6
pxq6t3 i5docs
28 Dec 04
Entry into a Material Definitive Agreement
12:00am